Pay in 4 interest-free payments of $7.07 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Extension Phase (Weeks 26-52) : In the double-blind Extension Phase, patients on tesamorelin completing the 26-week Main Phase were re-randomized to receive 2 mg tesamorelin or placebo
These patients should not be rechallenged with tirzepatide under any circumstances, as stated in the FDA prescribing information
No insurance is required, and both HSA and FSA accounts are eligible
Security professionals assessing network defenses
US$ 22.55
US$ 26.92
US$ 26.64
US$ 20.34
US$ 26.94
US$ 28.24
US$ 25.92
US$ 29.85
US$ 26.97
US$ 24.38
US$ 26.16
